Author:

Keywords:

Stroke, Reperfusion, MRI, PET, Endothelium, Science & Technology, Life Sciences & Biomedicine, Clinical Neurology, Neurosciences, Neurosciences & Neurology, SULFONYLUREA RECEPTOR 1, ISCHEMIC-STROKE, EXPRESSION, CHANNEL, BRAIN, Animals, Blood-Brain Barrier, Brain Edema, Disease Models, Animal, Fluorodeoxyglucose F18, Functional Laterality, Gene Expression Regulation, Image Processing, Computer-Assisted, Infarction, Middle Cerebral Artery, Male, Microarray Analysis, Multimodal Imaging, Phosphopyruvate Hydratase, RNA, Messenger, RNA, Small Interfering, Rats, Rats, Wistar, Reperfusion Injury, TRPM Cation Channels, von Willebrand Factor, 1103 Clinical Sciences, 1109 Neurosciences, 1117 Public Health and Health Services, 3202 Clinical sciences, 3209 Neurosciences

Abstract:

The transient receptor potential melastatin 4 (TRPM4) channel has been suggested to play a key role in the treatment of ischemic stroke. However, in vivo evaluation of TRPM4 channel, in particular by direct channel suppression, is lacking. In this study, we used multimodal imaging to assess edema formation and quantify the amount of metabolically functional brain salvaged after a rat model of stroke reperfusion. TRPM4 upregulation in endothelium emerges as early as 2 h post-stroke induction. Expression of TRPM4 channel was suppressed directly in vivo by treatment with siRNA; scrambled siRNA was used as a control. T2-weighted MRI suggests that TRPM4 inhibition successfully reduces edema by 30% and concomitantly salvages functionally active brain, measured by F-FDG-PET. These in vivo imaging results correlate well with post-mortem 2,3,5-triphenyltetrazolium chloride (TTC) staining which exhibits a 34.9% reduction in infarct volume after siRNA treatment. Furthermore, in a permanent stroke model, large areas of brain tissue displayed both edema and significant reductions in metabolic activity which was not shown in transient models with or without TRPM4 inhibition, indicating that tissue salvaged by TRPM4 inhibition during stroke reperfusion may survive. Evans Blue extravasation and hemoglobin quantification in the ipsilateral hemisphere were greatly reduced, suggesting that TRPM4 inhibition can improve BBB integrity after ischemic stroke reperfusion. Our results support the use of TRPM4 blocker for early stroke reperfusion.